HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials-Reference-Cited by-同舟云学术

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials

Published:2016-01-29 Issue:4 Volume:238 Page:562-570
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Richman Susan D¹,Southward Katie¹,Chambers Philip¹,Cross Debra²,Barrett Jennifer³,Hemmings Gemma¹,Taylor Morag¹,Wood Henry¹,Hutchins Gordon¹,Foster Joseph M⁴,Oumie Assa⁴,Spink Karen G⁴,Brown Sarah R⁵,Jones Marc⁵,Kerr David⁶,Handley Kelly⁷,Gray Richard⁸,Seymour Matthew⁹,Quirke Philip¹

Affiliation:

1. Section of Pathology and Tumour Biology Leeds Institute of Cancer and Pathology, University of Leeds UK

2. Histopathology and Molecular Pathology St James University Hospital Leeds UK

3. Section of Epidemiology and Biostatistics Leeds Institute of Cancer and Pathology, University of Leeds UK

4. Affymetrix UK Ltd High Wycombe UK

5. Clinical Trials Research Unit University of Leeds Leeds UK

6. Cancer Medicine University of Oxford UK

7. Birmingham Clinical Trials Unit University of Birmingham UK

8. Clinical Trials Service Unit and Epidemiology Studies Unit University of Oxford UK

9. Section of Oncology Leeds Institute of Cancer and Pathology, University of Leeds UK

Funder

Yorkshire Cancer Research

Cancer Research UK

Amgen

Technology Strategy Board

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.4679

Reference35 articles.

1. Global cancer statistics

2. EGF receptor

3. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

4. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

5. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and biological evaluation of 68Ga-labeled peptides for potential application in HER2-positive colorectal cancer;Bioorganic Chemistry;2024-10

2. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer;Biomedicine & Pharmacotherapy;2024-10

3. HER-2 directed therapies across gastrointestinal tract cancers – A new frontier;Cancer Treatment Reviews;2024-09

4. Systemic Therapy for Metastatic Colon Cancer: New Frontiers;Clinics in Colon and Rectal Surgery;2024-06-25

5. Current treatment options of HER2+ metastatic colorectal carcinoma;Onkologie;2024-06-24